|
Market Closed -
Australian S.E.
02:59:11 17/08/2026 +03
|
5-day change | 1st Jan Change | ||
| 0.0100 AUD | 0.00% |
|
-9.09% | -33.33% |
| 10:35am | Acrux Limited - Special Call | |
| 05-28 | Acrux licenses Lenzetto for Australian market for A$5.4 million | RE |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
Sector Generic Pharmaceuticals
| Capi. | Sales Growth | Profitability | Finances | EV / Sales | P/E | |
|---|---|---|---|---|---|---|
 | 4.18M | - | - | - | - | - |
| 48.43B | |||||
| 39.72B | |||||
| 12.25B | |||||
| 11.84B | |||||
| 9.06B |
- Stock Market
- Stocks
- ACR Stock
- Charts Acrux Limited
- Sector Chart
Select your edition
All financial news and data tailored to specific country editions
